LDL-Lowering Does Not Prevent CABG Graft Failure

Addition of the PCSK9 inhibitor evolocumab to statin therapy after CABG surgery does not improve 24-month graft patency, in the NEWTON-CABG CardioLink-5 trial.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/ldl-lowering-not-answer-cabg-graft-failure-2025a1000ok4?src=rss

Author :

Publish date : 2025-09-17 07:31:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

LDL-Lowering Does Not Prevent CABG Graft Failure

Higher VTE Risk in Patients With IBD After First CRC Surgery

NICE Recommends Durvalumab for Lung Cancer Patients

Related Posts

JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis

‘If That Doesn’t Blow Your Mind’: What We Heard This Week

Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women

Prevention Has a Branding Problem

Pool Data Back Safety of Newly Approved Non-Hormonal Treatment for Hot Flashes

What Vaccine Was Tied to Longer Cancer Survival?

JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis

‘If That Doesn’t Blow Your Mind’: What We Heard This Week

Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women

Prevention Has a Branding Problem

Pool Data Back Safety of Newly Approved Non-Hormonal Treatment for Hot Flashes

What Vaccine Was Tied to Longer Cancer Survival?

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Categories

Archives